Thimble Point Acquisition Corp. operated as a special purpose acquisition company, established in 2020 and based in New Haven, Connecticut. Its core mission was to identify and execute a business combination, such as a merger, asset acquisition, or stock exchange, with a promising target enterprise, specifically aiming for high-growth software and technology-enabled firms disrupting established markets. The company successfully completed its business combination with Pear Therapeutics in December 2021, though Pear Therapeutics later filed for bankruptcy in April 2023.